Recently, our lab succeeded to produce bio-based glycolipid bolaamphiphile on a gram scale by using the genetically-engineered S. bombicola strain Δat Δsble Δfao1 (Van Renterghem et al., Biotechnol. Bioeng., 2018, 115, 1195–1206). This article show that the bio-based glyco-bolaamphiphile readily forms a hydrogel in water at room temperature, and that the hydrogel formation depends on the formation of self-assembled fibers. Here, you can find more information Read more about Article in ‘Soft Matter’ : Bio-based glyco-bolaamphiphile forms a temperature-responsive hydrogel with tunable elastic properties[…]
In 2019, a Massive Open Online Course (MOOC) will be kicked off, in which InBio.be is participating. The MOOC is organized by Bio Innovation Growth mega Cluster (BIG-Cluster). The BIG-Cluster aims at building a coordinated education and training initiative with focus on academic education in a cross-border approach with partners from the BIG-Cluster region: the Cross-border BioEconomy Education CROSSBEE. The MOOCs Read more about Coming soon: MOOC[…]
Currently, there is a lot of interest in bolaamphiphiles because of the unusual architecture created by such molecules as they possess not one but two hydrophilic heads, coupled by a hydrophobic linker. Only a limited amount of bolaamhiphiles can be produced microbially. Applying a combination of white biotechnology and green chemistry can dramatically increase the structural possibilities starting from Read more about A research article about bolaamphiphilic sophorolipids is published in ACS Sustainable Chemistry & Engineering[…]
A new article was published in the journal ‘Green Chemistry’. Herein, complex coacervation of micelles from a bolaform sophorolipid biosurfactant with oppositely charged cationic polyelectrolytes (i.e., chitosan oligosaccharide lactate, poly (L-lysine) and poly(allylamine)) was investigated. You can find the article here.
On the 1st of August, a new project will start at InBio.be that focuses on expanding the functional portfolio of biosurfactants. The research partners that will contribute to this project are Ghent University (Faculty Bioscience Engineering InBio.be, Faculty Green Chemistry and Technology SynBioc en Honeybee Valley), Bio Base Europe Pilot Plant, Flanders Materials Centre (FLAMAC) Read more about New project ‘AppliSurf’ starts on the 1st of August![…]
In our newest review article “Starmerella bombicola, an industrially relevant, yet fundamentally underexplored yeast”, the focus is laid on the discovery, taxonomy, habitat, cellular characteristics, biochemistry and genetics of this non-pathogenic yeast. You can find the minireview in FEMS Yeast Research right here.
From 18th to 22nd June 2018, an ICGEB course about “Development of surface active compounds from microorganisms: production, characterization and evaluation” took place in (Guayaquil) Ecuador. The patented technology platform around innovative and new glycolipids developed at InBio.be was presented by dr. Sophie Roelants.
Our new book chapter ‘Transformation of an Exotic Yeast Species into a Platform Organism: A Case Study for Engineering Glycolipid Production in the Yeast Starmerella bombicola’ is published in ‘Synthetic biology: Methods and protocols’. In this chapter, a step-by-step approach on how to transform non-conventional yeasts or fungi into platform organisms is described. The non-conventional glycolipid producing yeast Starmerella bombicola (and Read more about Check out our book chapter in ‘Synthetic Biology: Methods and Protocols’[…]
Click here to read Prof. Wim Soetaert ‘s last column, published in Petrochem 05-2018.
On the 27 st of March 2018, DuPont Nutrition & Health and Inbiose NV celebrated the regulatory approval of their first human milk oligosaccharide (HMO) ingredient for infant formula in the European market: 2’-fucosyllactose (2’-FL)! Human milk oligosaccharides, complex carbohydrates found in breast milk, are an important breakthrough innovation in infant formula, developing a Read more about Regulatory approval of the first human milk oligosaccharide (HMO) in Europe[…]